---
title: "NewcelX Ltd. (NCEL.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/NCEL.US.md"
symbol: "NCEL.US"
name: "NewcelX Ltd."
industry: "Biotechnology"
datetime: "2026-05-21T17:49:36.986Z"
locales:
  - [en](https://longbridge.com/en/quote/NCEL.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NCEL.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NCEL.US.md)
---

# NewcelX Ltd. (NCEL.US)

## Company Overview

NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company was founded in 2008 and is headquartered in Zurich, Switzerland.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [newcelx.com](https://newcelx.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -2.11 | 248 | - | - | - |
| PB | 2.41 | 214 | 2.41 | 2.31 | 2.09 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/NCEL.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/NCEL.US/norm.md)
- [Related News](https://longbridge.com/en/quote/NCEL.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/NCEL.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**